We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CAMT:TASECamtek Ltd Analysis

Data as of 2026-03-12 - not real-time

$161.35

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Camtek Ltd. (CAMT) is trading at $161.35, comfortably above its 20‑day SMA of 159.93 and the 50‑day SMA of 146.33, indicating short‑term bullish momentum despite a recent earnings miss where EPS came in at $0.81 versus the $0.83 consensus. The RSI sits near the mid‑range at 54.5, suggesting neither overbought nor oversold conditions, while the MACD histogram is negative (-1.63) and the signal line is bearish, hinting at potential downside pressure. Fundamental metrics reveal a steep trailing P/E of 152x versus an industry average of 34.6x, marking the stock as significantly overvalued, though the forward P/E of 37x offers a slightly more tempered view. Revenue for FY‑2025 reached $496 million, up 9% YoY, and forward EPS is projected to rise to $4.33, underscoring solid growth prospects. The balance sheet is cash‑rich with $668 million in cash against $520 million of debt, yielding a debt‑to‑equity of 84%, and the company generates no dividend.
The stock’s beta of 1.84 and 30‑day volatility of over 66% signal heightened market sensitivity, while volume trends are decreasing, adding a liquidity caution. Analyst consensus remains positive with a “buy” rating from 12 analysts and a median price target of $175, reflecting confidence in the company’s advanced packaging platform and AI‑driven inspection tools. However, the combination of high valuation multiples, earnings miss, and elevated risk metrics suggests a measured approach: hold in the near term, consider buying on pull‑backs, and monitor macro‑ and geopolitical factors that could affect its global customer base.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above short‑term SMAs but MACD bearish divergence
  • Recent EPS miss versus consensus
  • Elevated valuation multiples

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Solid revenue growth and strong forward EPS outlook
  • Robust cash position relative to debt
  • Analyst consensus and price‑target upside

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Long‑term secular demand for advanced packaging inspection
  • Persistent overvaluation relative to peers
  • High beta and volatility warrant cautious exposure

Key Metrics & Analysis

Financial Health

Revenue Growth9.20%
Profit Margin10.22%
P/E Ratio152.2
ROE8.70%
ROA7.48%
Debt/Equity84.25
P/B Ratio12.0
Industry P/E34.6

Technical Analysis

TrendBullish
RSI54.5
Support$142.35
Resistance$174.61
MA 20$159.93
MA 50$146.33
MA 200$108.80
MACDBearish
VolumeDecreasing
Fear & Greed Index78.16

Valuation

Target Price$168.83
Upside/Downside4.64%
GradeOvervalued
TypeBlend

Risk Assessment

Beta1.84
Volatility66.16%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.